Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma - Blood Cancers OncTalk 2023 GRACE - Global Resource for Advancing Cancer Education 2:47 11 months ago 141 Далее Скачать
Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma GRACE - Global Resource for Advancing Cancer Education 3:02 8 months ago 289 Далее Скачать
Bispecific Antibody Treatment in Non-Hodgkin Lymphoma: Glofitamab - Blood Cancers OncTalk 2023 GRACE - Global Resource for Advancing Cancer Education 2:52 11 months ago 83 Далее Скачать
Treatment Options of B-Cell Lymphoma: Glofitamab vs. Epcoritamab - Blood Cancer Video Library 2023 GRACE - Global Resource for Advancing Cancer Education 4:22 5 months ago 516 Далее Скачать
The current and future role of bispecifics in R/R DLBCL: epcoritamab, glofitamab & more VJHemOnc – Video Journal of Hematology & HemOnc 2:08 1 year ago 370 Далее Скачать
Glofitamab and epcoritamab in the real-world setting: a UK multi-center retrospective analysis VJHemOnc – Video Journal of Hematology & HemOnc 2:18 10 days ago 43 Далее Скачать
ASH highlights: glofitamab in DLBCL & pirtobrutinib and epcoritamab in Richter's transformation VJHemOnc – Video Journal of Hematology & HemOnc 1:58 1 year ago 359 Далее Скачать
CD20/CD3 bispecific antibodies in R/R DLBCL: glofitamab and epcoritamab VJHemOnc – Video Journal of Hematology & HemOnc 1:21 7 months ago 380 Далее Скачать
Bispecific antibodies for R/R aggressive B-cell lymphomas VJHemOnc – Video Journal of Hematology & HemOnc 1:30 1 year ago 216 Далее Скачать
Advantages of bispecific antibodies for lymphoma: mosunetuzumab, epcoritamab & glofitamab VJHemOnc – Video Journal of Hematology & HemOnc 1:31 1 year ago 777 Далее Скачать
Phase II study of epcoritamab in R/R LBCL VJHemOnc – Video Journal of Hematology & HemOnc 1:38 2 years ago 729 Далее Скачать
Michael Dickinson, MBBS, DMedSc, on a Phase II Trial of Glofitamab in DLBCL Blood Cancers Today 6:47 2 years ago 192 Далее Скачать
Updates from the Phase II trials of glofitamab and epcoritamab for R/R LBCL VJHemOnc – Video Journal of Hematology & HemOnc 1:49 1 month ago 74 Далее Скачать
Follow-up results of EPCORE NHL-1: subcutaneous epcoritamab in R/R LBCL VJHemOnc – Video Journal of Hematology & HemOnc 1:49 1 year ago 511 Далее Скачать
The emerging potential of bispecific antibodies as monotherapy & in combination for B-cell lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 5:12 2 years ago 277 Далее Скачать
Glofitamab as a single agent in heavily pretreated patients with DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 2:33 1 year ago 301 Далее Скачать
The next generation of novel agents in development for aggressive B-cell lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 2:03 2 years ago 103 Далее Скачать
Glofitamab in R/R DLBCL: updated safety and efficacy data VJHemOnc – Video Journal of Hematology & HemOnc 5:30 1 year ago 456 Далее Скачать
An update on the EPCORE NHL-1 trial VJHemOnc – Video Journal of Hematology & HemOnc 1:35 2 years ago 187 Далее Скачать
Updates in bispecifics for DLBCL from ASH: glofitamab, odronextamab, epcoritamab & mosunetuzumab VJHemOnc – Video Journal of Hematology & HemOnc 4:31 1 year ago 1 090 Далее Скачать
